XTI Aerospace Names Unusual Machines CEO Allan Evans Chairman

Image
XTI Aerospace Names Unusual Machines CEO Allan Evans Chairman

Dallas – October 14, 2026 -- XTI Aerospace (Nasdaq: XTIA) has appointed Dr. Allan Evans, CEO of rival-sector drone firm Unusual Machines (NYSE American: UMAC), as director and Chairman of its Board, returning the board to five members.

Jonathan Ornstein has been designated Vice Chairman in connection with the appointment. XTI is the parent company of Drone Nerds, LLC, a drone solutions platform serving commercial, enterprise and government customers.

Evans brings drone supply chain and executive experience from three companies

Evans, 43, has served as CEO and director of Unusual Machines since December 2023. From 2021 to 2023 he was Chief Operating Officer of Red Cat Holdings. He previously led Fat Shark as CEO from 2017 until Red Cat acquired it in 2020. He holds a PhD in Electrical Engineering from the University of Michigan.

Pet Food Ingredients Market to Reach USD 57.68B by 2031

Image
Pet Food Ingredients Market to Reach USD 57.68B by 2031

Delray Beach – October 14, 2026 -- The pet food ingredients market will grow from USD 41.55 billion in 2026 to USD 57.68 billion by 2031, a 6.8% CAGR, according to MarketsandMarkets.

Animal-based ingredients hold 53.8% share as premiumization lifts meat inclusion

The animal-based segment is estimated to lead the market with a 53.8% share in 2026. The report also expects it to be the fastest-growing source segment through 2031. Manufacturers are differentiating products with higher meat inclusion, novel proteins and species-specific formulations.

Fresh, refrigerated, freeze-dried and air-dried formats are opening additional demand for meat, poultry, fish and egg ingredients. Insect and marine-based proteins are broadening the ingredient base and addressing sustainability and supply-chain considerations.

Timken to Report Q3 2026 Results on Nov. 4 Before NYSE Open

Image
Timken to Report Q3 2026 Results on Nov. 4 Before NYSE Open

North Canton – October 14, 2026 -- The Timken Company (NYSE: TKR) will release its 2026 third-quarter financial results on Wednesday, November 4, before the New York Stock Exchange opens.

Timken schedules same-day investor call to discuss Q3 performance

The company will host a conference call on November 4 to discuss its financial performance with investors and securities analysts. Financial results and conference call materials will be available on the company's investor relations website.

Release follows $4.6 billion in 2025 sales across 45 countries

Timken posted $4.6 billion in sales in 2025. It employs approximately 19,000 people and operates from 45 countries. The company serves strategic end markets including aerospace and defense, power and electrification, and automation and industrial solutions.

Battery Thermal Management Market to Hit $10.97B by 2033

Image
Battery Thermal Management Market to Hit $10.97B by 2033

Delray Beach – October 14, 2026 -- The battery thermal management system (BTMS) market will grow from USD 5.26 billion in 2026 to USD 10.97 billion by 2033, a compound annual growth rate of 11.1%, according to MarketsandMarkets.

Fast-charging and 800 V platforms push OEMs from air cooling to liquid-cooled architectures

Higher battery energy density, faster charging, greater power output and stricter safety requirements are raising the value and technology content of BTMS. OEMs are moving from conventional air cooling to liquid-cooled and integrated thermal architectures. The technology is also shifting toward AI-based thermal simulation, cell-level temperature monitoring, direct cell cooling and intelligent controls. 800 V platforms need higher coolant flow, faster preconditioning and integrated battery heating and cooling.

Garmin Autoland Passes 2,500 Aircraft Six Years After Certification

Image
Garmin Autoland Passes 2,500 Aircraft Six Years After Certification

Olathe, Kan. – October 14, 2026 -- More than 2,500 aircraft are now equipped with Garmin Autoland, just over six years after the system's first certification, Garmin (NYSE: GRMN) announced. The technology is available on more than 15 aircraft models, spanning piston-powered aircraft and twin-engine jets.

Garmin describes Autoland as the world's first certified autonomous system that activates in an emergency to control and land an aircraft without human intervention. It has won the Robert J. Collier Trophy.

Four 2026 certifications extend Autoland into twin-engine jets

Autoland was first certified in May 2020 on the Piper M600 SLS. In 2026 alone, it gained certification on four more models: the HondaJet Elite II, Embraer Phenom 300EV, Pilatus PC-12 PRO and Epic E1000 AX.

AEP to Invest $4B in 702-MW Fuel Cell Plant for Google

Image
AEP to Invest $4B in 702-MW Fuel Cell Plant for Google

Columbus – October 14, 2026 -- American Electric Power (Nasdaq: AEP) plans to invest approximately $4 billion in a 702-megawatt fuel cell generation project near Cheyenne, Wyoming, backed by a 20-year power purchase agreement (PPA) with Google.

AEP controls 92% of the project company, Basalt funds hold nearly 8%

Google will buy power from Cheyenne Fuel Cell, LLC. AEP owns and controls about 92% of the entity, and funds advised by Basalt Infrastructure Partners, LLP hold nearly 8%. AEP and its partners plan to start construction in 2026. The facility is expected to be fully operational by the end of 2028.

TULSA Outperforms Robotic Prostatectomy on Function in CAPTAIN Trial

Image
TULSA Outperforms Robotic Prostatectomy on Function in CAPTAIN Trial

TORONTO – October 14, 2026 -- Patients treated with whole-gland TULSA were more than twice as likely to preserve both erectile function and pad-free continence at six months as those who had robotic radical prostatectomy (risk ratio 2.1; p=0.004), according to CAPTAIN trial data. Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) presented the results among five abstracts at the 15th Interventional MRI Symposium in Boston.

CAPTAIN trial shows whole-gland TULSA cut complication hospitalizations to 0.7% versus 6.3% for robotic surgery

CAPTAIN is the first fully enrolled, multicenter randomized controlled trial to compare the TULSA Procedure directly with robotic radical prostatectomy in localized intermediate-risk prostate cancer. Whole-gland TULSA also showed statistically superior preservation of flaccid penile length at one month.

EP YAYING Launches SS27 Line for Global Buyers at MODE Shanghai

Image
EP YAYING Launches SS27 Line for Global Buyers at MODE Shanghai

Shanghai – October 14, 2026 -- Chinese luxury label EP YAYING is using its second consecutive appearance at the Shanghai Fashion Week MODE trade show, October 8 to 12, 2026, to launch its Spring/Summer 2027 collection to international buyers across five product directions.

The brand is exhibiting at Booth F17-01, Tower T2, Jingyao Hongqiao, 688 Tianshan Road, Changning. It first joined MODE in March 2026.

Three Chinese natural materials anchor the SS27 offer

EP YAYING builds the collection on what it calls the "YAYING Three Treasures." The first is 6A-grade mulberry silk from the brand's organic sericulture base in Ningnan, Sichuan, used for lightweight spring/summer apparel and textiles.

The second is snowfield yak down, sourced through supply-chain collaboration with Aba and Nagqu. It is naturally collected and processed with low-dyeing methods for knitwear and light outerwear.

Carnyx's CNYX-005 Adds 1.5-2 Hours of Sleep in Aged Rat Study

Image
Carnyx's CNYX-005 Adds 1.5-2 Hours of Sleep in Aged Rat Study

Indianapolis – October 14, 2026 -- Carnyx Therapeutics Ltd. unveiled CNYX-005, an oral sleep candidate that increased total sleep time by roughly 1.5 to 2 hours in aged rats versus a control arm, as the preclinical-stage company moves toward clinical development.

The increase was driven primarily by more non-rapid eye movement (NREM) sleep. Researchers measured sleep architecture using continuous electroencephalography (EEG) monitoring.

Carnyx hires Chris Brearley, M.D., as Chief Medical Officer ahead of clinical entry

Brearley brings more than 30 years of experience in translational medicine, clinical pharmacology and early-stage drug development. His prior roles include senior positions at Pfizer, Amgen and Serono. He has designed and overseen first-in-human and early-stage clinical studies, the stage CNYX-005 now approaches.

Brearley said he aims to translate the findings into a rigorous clinical development program.

CSTS Enterprises Adds CUHK's Robert Li to Advisory Board

Image
CSTS Enterprises Adds CUHK's Robert Li to Advisory Board

New York – October 14, 2026 -- CSTS Enterprises, a New York-based sports, entertainment, integrated media and travel technology group, has appointed Professor Robert Li, who heads the School of Hotel and Tourism Management at The Chinese University of Hong Kong (CUHK) Business School, to its Advisory Board.

Li will advise CSTS on sports tourism and hospitality innovation

Li will provide strategic guidance on sports tourism, hospitality innovation and the broader experience economy. CSTS is expanding its international footprint and developing new hospitality products, partnerships and experiences for clients, destinations and global audiences.

Group CEO and Executive Director Abel Zhao called Li "one of the most respected voices in global tourism and hospitality."